Patents by Inventor Rajeshwer SANKHALA

Rajeshwer SANKHALA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibitors for coronavirus
    Patent number: 11963959
    Abstract: Inhibitors against SARS-COV-1, SARS-CoV-2 (Covid-19), MERS-CoV, and variants within each, including methods of treating a subject suffering from such respiratory disease.
    Type: Grant
    Filed: August 12, 2022
    Date of Patent: April 23, 2024
    Assignees: Southwest Research Institute, The Government of the United States, as represented by The Secretary of the Army, The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
    Inventors: Jonathan A. Bohmann, Nadean M. Gutierrez, Joseph A. Mcdonough, Robert Francis Campbell, Michael Gordon Joyce, Rekha Panchal, Rajeshwer Sankhala, Allen Duplantier
  • Antiviral drugs targeting the N-terminal domain (NTD) of the coronavirus spike receptor binding domain (RBD)
    Patent number: 11865111
    Abstract: Antiviral drugs targeting the N-terminal domain (NTD) of the spike receptor binding domain (RBD) and methods of treating a subject suffering from coronavirus.
    Type: Grant
    Filed: August 11, 2022
    Date of Patent: January 9, 2024
    Assignees: Southwest Research Institute, The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., The Government of the United States, as Represented by the Secretary of the Army
    Inventors: Jonathan A. Bohmann, Nadean M. Gutierrez, Joseph A. McDonough, Robert Francis Campbell, Michael Gordon Joyce, Rekha Panchal, Rajeshwer Sankhala, Allen Duplantier
  • ANTIVIRAL DRUGS TARGETING THE N-TERMINAL DOMAIN (NTD) OF THE CORONAVIRUS SPIKE RECEPTOR BINDING DOMAIN (RBD)
    Publication number: 20230074535
    Abstract: Antiviral drugs targeting the N-terminal domain (NTD) of the spike receptor binding domain (RBD) and methods of treating a subject suffering from coronavirus.
    Type: Application
    Filed: August 11, 2022
    Publication date: March 9, 2023
    Inventors: Jonathan A. BOHMANN, Nadean M. GUTIERREZ, Joseph A. MCDONOUGH, Robert Francis CAMPBELL, Michael Gordon JOYCE, Rekha PANCHAL, Rajeshwer SANKHALA, Allen DUPLANTIER
  • INHIBITORS FOR CORONAVIRUS
    Publication number: 20230065024
    Abstract: Inhibitors against SARS-COV-1, SARS-CoV-2 (Covid-19), MERS-CoV, and variants within each, including methods of treating a subject suffering from such respiratory disease.
    Type: Application
    Filed: August 12, 2022
    Publication date: March 2, 2023
    Inventors: Jonathan A. BOHMANN, Nadean M. GUTIERREZ, Joseph A. MCDONOUGH, Robert Francis CAMPBELL, Michael Gordon JOYCE, Rekha PANCHAL, Rajeshwer SANKHALA, Allen DUPLANTIER